Fibroblast Growth Factor Receptor 3 Mutation as a Prognostic Indicator in Patients with Urothelial Carcinoma: A Systematic Review and Meta-analysis

Fibroblast Growth Factor Receptor 3 Mutation as a Prognostic Indicator in Patients with Urothelial Carcinoma: A Systematic Review and Meta-analysis

Background: Fibroblast growth factor receptor 3 (FGFR3) mutations have been implicated in urothelial tumorigenesis. FGFR3 inhibitors are being explored in clinical trials. Objective: We aimed to study the association between FGFR3 mutations and survival in urothelial carcinoma. Design, setting, and...

Full description

Bibliographic Details
Main Authors: Sidra Khalid, Bassam Mohammed Basulaiman, Jeffrey Emack, Christopher M. Booth, Ignacio Duran, Andrew G. Robinson, David Berman, Martin Smoragiewicz, Eitan Amir, Francisco E. Vera-Badillo
Format: Article
Language:English
Published: Elsevier 2020-10-01
Series:European Urology Open Science
Subjects:
Fibroblast growth factor receptor 3 mutation
Muscle invasive
Non-muscle invasive
Progression-free survival
Recurrence-free survival
Urothelial carcinoma
Online Access:http://www.sciencedirect.com/science/article/pii/S2666168320353179

Internet

http://www.sciencedirect.com/science/article/pii/S2666168320353179

Similar Items